PROT fundamentals

Key facts

—

—

—

—

—

—

—

—

About

Proteonomix, Inc. is a biotechnology company, which engages in the discovery and development of stem cell therapeutic and cosmeceutical products. It develops pre-clinical stage therapeutic agents and treatments for diabetes, heart, and lung diseases. The company was founded by Michael Moshe Cohen on June 26, 1995 and is headquartered in Paramus, NJ.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

PROT has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company